Uncategorized
Addition of intravitreal chemotherapy boosts salvage rate in retinoblastoma
The addition of intravitreal chemotherapy to strategies for treating retinoblastoma represents an improvement in management of the disease, according to a study. Researchers included 66 eyes of 66 patients with unilateral retinoblastoma from two treatment eras. Era I (27 eyes) included patients treated with intra-arterial chemotherapy alone in the period 2008 to 2012, and era II (39 eyes) included patients treated with intra-arterial chemotherapy plus intravitreal chemotherapy, as needed to address vitreous seed activity, in the period 2012 to 2015. Only seven patients in the era II group were deemed (Read more...)